$3480 | Single User
$5980 | Site License
$5980 | Global License

Multiple Myeloma Treatment-Global Market Status and Trend Report 2013-2023
[Report Updated: 23-10-2017]

Published by MIReports: 23 Oct 2017 | 135915 | In Stock
Related Topics: Roche

Introduction

Report Summary

Naproxen-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Naproxen industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole United States and Regional Market Size of Naproxen 2013-2017, and development forecast 2018-2023

Main market players of Naproxen in United States, with company and product introduction, position in the Naproxen market

Market status and development trend of Naproxen by types and applications

Cost and profit status of Naproxen, and marketing status

Market growth drivers and challenges

The report segments the United States Naproxen market as:

United States Naproxen Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

New England

The Middle Atlantic

The Midwest

The West

The South

Southwest

United States Naproxen Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Tablet

Capsule

Other

United States Naproxen Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Application 1

Application 2

Application 3

Application 4

Application 5

United States Naproxen Market: Players Segment Analysis (Company and Product introduction, Naproxen Sales Volume, Revenue, Price and Gross Margin):

Roche

Divis Laboratories

Taj Pharmaceuticals Limited

GLORIA

HUANLON

PKU HIGH-TECH HUATAI

SINE

Bayer

YAOPHARMA

PharmEvo

APOTEX

Schazoo

Aspen Pharmacare

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents
for Multiple Myeloma Treatment-Global Market Status and Trend Report 2013-2023 [Report Updated: 23-10-2017]

  • Table of Contents

    Chapter 1 Overview of Naproxen

    1.1 Definition of Naproxen in This Report

    1.2 Commercial Types of Naproxen

    1.2.1 Tablet

    1.2.2 Capsule

    1.2.3 Other

    1.3 Downstream Application of Naproxen

    1.3.1 Application 1

    1.3.2 Application 2

    1.3.3 Application 3

    1.3.4 Application 4

    1.3.5 Application 5

    1.4 Development History of Naproxen

    1.5 Market Status and Trend of Naproxen 2013-2023

    1.5.1 United States Naproxen Market Status and Trend 2013-2023

    1.5.2 Regional Naproxen Market Status and Trend 2013-2023

    Chapter 2 United States Market Status and Forecast by Regions

    2.1 Market Status of Naproxen in United States 2013-2017

    2.2 Consumption Market of Naproxen in United States by Regions

    2.2.1 Consumption Volume of Naproxen in United States by Regions

    2.2.2 Revenue of Naproxen in United States by Regions

    2.3 Market Analysis of Naproxen in United States by Regions

    2.3.1 Market Analysis of Naproxen in New England 2013-2017

    2.3.2 Market Analysis of Naproxen in The Middle Atlantic 2013-2017

    2.3.3 Market Analysis of Naproxen in The Midwest 2013-2017

    2.3.4 Market Analysis of Naproxen in The West 2013-2017

    2.3.5 Market Analysis of Naproxen in The South 2013-2017

    2.3.6 Market Analysis of Naproxen in Southwest 2013-2017

    2.4 Market Development Forecast of Naproxen in United States 2018-2023

    2.4.1 Market Development Forecast of Naproxen in United States 2018-2023

    2.4.2 Market Development Forecast of Naproxen by Regions 2018-2023

    Chapter 3 United States Market Status and Forecast by Types

    3.1 Whole United States Market Status by Types

    3.1.1 Consumption Volume of Naproxen in United States by Types

    3.1.2 Revenue of Naproxen in United States by Types

    3.2 United States Market Status by Types in Major Countries

    3.2.1 Market Status by Types in New England

    3.2.2 Market Status by Types in The Middle Atlantic

    3.2.3 Market Status by Types in The Midwest

    3.2.4 Market Status by Types in The West

    3.2.5 Market Status by Types in The South

    3.2.6 Market Status by Types in Southwest

    3.3 Market Forecast of Naproxen in United States by Types

    Chapter 4 United States Market Status and Forecast by Downstream Industry

    4.1 Demand Volume of Naproxen in United States by Downstream Industry

    4.2 Demand Volume of Naproxen by Downstream Industry in Major Countries

    4.2.1 Demand Volume of Naproxen by Downstream Industry in New England

    4.2.2 Demand Volume of Naproxen by Downstream Industry in The Middle Atlantic

    4.2.3 Demand Volume of Naproxen by Downstream Industry in The Midwest

    4.2.4 Demand Volume of Naproxen by Downstream Industry in The West

    4.2.5 Demand Volume of Naproxen by Downstream Industry in The South

    4.2.6 Demand Volume of Naproxen by Downstream Industry in Southwest

    4.3 Market Forecast of Naproxen in United States by Downstream Industry

    Chapter 5 Market Driving Factor Analysis of Naproxen

    5.1 United States Economy Situation and Trend Overview

    5.2 Naproxen Downstream Industry Situation and Trend Overview

    Chapter 6 Naproxen Market Competition Status by Major Players in United States

    6.1 Sales Volume of Naproxen in United States by Major Players

    6.2 Revenue of Naproxen in United States by Major Players

    6.3 Basic Information of Naproxen by Major Players

    6.3.1 Headquarters Location and Established Time of Naproxen Major Players

    6.3.2 Employees and Revenue Level of Naproxen Major Players

    6.4 Market Competition News and Trend

    6.4.1 Merger, Consolidation or Acquisition News

    6.4.2 Investment or Disinvestment News

    6.4.3 New Product Development and Launch

    Chapter 7 Naproxen Major Manufacturers Introduction and Market Data

    7.1 Roche

    7.1.1 Company profile

    7.1.2 Representative Naproxen Product

    7.1.3 Naproxen Sales, Revenue, Price and Gross Margin of Roche

    7.2 Divis Laboratories

    7.2.1 Company profile

    7.2.2 Representative Naproxen Product

    7.2.3 Naproxen Sales, Revenue, Price and Gross Margin of Divis Laboratories

    7.3 Taj Pharmaceuticals Limited

    7.3.1 Company profile

    7.3.2 Representative Naproxen Product

    7.3.3 Naproxen Sales, Revenue, Price and Gross Margin of Taj Pharmaceuticals Limited

    7.4 GLORIA

    7.4.1 Company profile

    7.4.2 Representative Naproxen Product

    7.4.3 Naproxen Sales, Revenue, Price and Gross Margin of GLORIA

    7.5 HUANLON

    7.5.1 Company profile

    7.5.2 Representative Naproxen Product

    7.5.3 Naproxen Sales, Revenue, Price and Gross Margin of HUANLON

    7.6 PKU HIGH-TECH HUATAI

    7.6.1 Company profile

    7.6.2 Representative Naproxen Product

    7.6.3 Naproxen Sales, Revenue, Price and Gross Margin of PKU HIGH-TECH HUATAI

    7.7 SINE

    7.7.1 Company profile

    7.7.2 Representative Naproxen Product

    7.7.3 Naproxen Sales, Revenue, Price and Gross Margin of SINE

    7.8 Bayer

    7.8.1 Company profile

    7.8.2 Representative Naproxen Product

    7.8.3 Naproxen Sales, Revenue, Price and Gross Margin of Bayer

    7.9 YAOPHARMA

    7.9.1 Company profile

    7.9.2 Representative Naproxen Product

    7.9.3 Naproxen Sales, Revenue, Price and Gross Margin of YAOPHARMA

    7.10 PharmEvo

    7.10.1 Company profile

    7.10.2 Representative Naproxen Product

    7.10.3 Naproxen Sales, Revenue, Price and Gross Margin of PharmEvo

    7.11 APOTEX

    7.11.1 Company profile

    7.11.2 Representative Naproxen Product

    7.11.3 Naproxen Sales, Revenue, Price and Gross Margin of APOTEX

    7.12 Schazoo

    7.12.1 Company profile

    7.12.2 Representative Naproxen Product

    7.12.3 Naproxen Sales, Revenue, Price and Gross Margin of Schazoo

    7.13 Aspen Pharmacare

    7.13.1 Company profile

    7.13.2 Representative Naproxen Product

    7.13.3 Naproxen Sales, Revenue, Price and Gross Margin of Aspen Pharmacare

    Chapter 8 Upstream and Downstream Market Analysis of Naproxen

    8.1 Industry Chain of Naproxen

    8.2 Upstream Market and Representative Companies Analysis

    8.3 Downstream Market and Representative Companies Analysis

    Chapter 9 Cost and Gross Margin Analysis of Naproxen

    9.1 Cost Structure Analysis of Naproxen

    9.2 Raw Materials Cost Analysis of Naproxen

    9.3 Labor Cost Analysis of Naproxen

    9.4 Manufacturing Expenses Analysis of Naproxen

    Chapter 10 Marketing Status Analysis of Naproxen

    10.1 Marketing Channel

    10.1.1 Direct Marketing

    10.1.2 Indirect Marketing

    10.1.3 Marketing Channel Development Trend

    10.2 Market Positioning

    10.2.1 Pricing Strategy

    10.2.2 Brand Strategy

    10.2.3 Target Client

    10.3 Distributors/Traders List

    Chapter 11 Report Conclusion

    Chapter 12 Research Methodology and Reference

    12.1 Methodology/Research Approach

    12.1.1 Research Programs/Design

    12.1.2 Market Size Estimation

    12.1.3 Market Breakdown and Data Triangulation

    12.2 Data Source

    12.2.1 Secondary Sources

    12.2.2 Primary Sources

    12.3 Reference

List Of Tables
in Multiple Myeloma Treatment-Global Market Status and Trend Report 2013-2023 [Report Updated: 23-10-2017]

List of Tables


Table Advantage and Disadvantage of Tablet

Table Advantage and Disadvantage of Capsule

Table Advantage and Disadvantage of Other

Table Consumption Volume of Naproxen in United States by Regions 2013-2017

Table Revenue of Naproxen in United States by Regions 2013-2017

Table Consumption Volume of Naproxen in United States by Regions 2018-2023

Table Revenue of Naproxen in United States by Regions 2018-2023

Table Consumption Volume of Naproxen in United States by Types 2013-2017

Table Revenue of Naproxen in United States by Types 2013-2017

Table Consumption Volume of Naproxen by Types in New England 2013-2017

Table Consumption Volume of Naproxen by Types in The Middle Atlantic 2013-2017

Table Consumption Volume of Naproxen by Types in The Midwest 2013-2017

Table Consumption Volume of Naproxen by Types in The West 2013-2017

Table Consumption Volume of Naproxen by Types in The South 2013-2017

Table Consumption Volume of Naproxen by Types in Southwest 2013-2017

Table Consumption Volume Forecast of Naproxen in United States by Types 2018-2023

Table Revenue Forecast of Naproxen in United States by Types 2018-2023

Table Demand Volume of Naproxen in United States by Downstream Industry 2013-2017

Table Demand Volume of Naproxen by Downstream Industry in New England 2013-2017

Table Demand Volume of Naproxen by Downstream Industry in The Middle Atlantic 2013-2017

Table Demand Volume of Naproxen by Downstream Industry in The Midwest 2013-2017

Table Demand Volume of Naproxen by Downstream Industry in The West 2013-2017

Table Demand Volume of Naproxen by Downstream Industry in The South 2013-2017

Table Demand Volume of Naproxen by Downstream Industry in Southwest 2013-2017

Table Demand Volume Forecast of Naproxen in United States by Downstream Industry 2018-2023

Table Sales Volume of Naproxen in United States by Major Players 2013-2017

Table Revenue of Naproxen in United States by Major Players 2013-2017

Table Headquarters Location and Established Time of Naproxen Major Players

Table Employees and Revenue Level of Naproxen Major Players

Table Representative Naproxen Product One of Roche

Table Representative Naproxen Product Two of Roche

Table Naproxen Sales, Revenue, Price and Gross Margin of Roche 2013-2017

Table Representative Naproxen Product One of Divis Laboratories

Table Representative Naproxen Product Two of Divis Laboratories

Table Naproxen Sales, Revenue, Price and Gross Margin of Divis Laboratories 2013-2017

Table Representative Naproxen Product One of Taj Pharmaceuticals Limited

Table Representative Naproxen Product Two of Taj Pharmaceuticals Limited

Table Naproxen Sales, Revenue, Price and Gross Margin of Taj Pharmaceuticals Limited 2013-2017

Table Representative Naproxen Product One of GLORIA

Table Representative Naproxen Product Two of GLORIA

Table Naproxen Sales, Revenue, Price and Gross Margin of GLORIA 2013-2017

Table Representative Naproxen Product One of HUANLON

Table Representative Naproxen Product Two of HUANLON

Table Naproxen Sales, Revenue, Price and Gross Margin of HUANLON 2013-2017

Table Representative Naproxen Product One of PKU HIGH-TECH HUATAI

Table Representative Naproxen Product Two of PKU HIGH-TECH HUATAI

Table Naproxen Sales, Revenue, Price and Gross Margin of PKU HIGH-TECH HUATAI 2013-2017

Table Representative Naproxen Product One of SINE

Table Representative Naproxen Product Two of SINE

Table Naproxen Sales, Revenue, Price and Gross Margin of SINE 2013-2017

Table Representative Naproxen Product One of Bayer

Table Representative Naproxen Product Two of Bayer

Table Naproxen Sales, Revenue, Price and Gross Margin of Bayer 2013-2017

Table Representative Naproxen Product One of YAOPHARMA

Table Representative Naproxen Product Two of YAOPHARMA

Table Naproxen Sales, Revenue, Price and Gross Margin of YAOPHARMA 2013-2017

Table Representative Naproxen Product One of PharmEvo

Table Representative Naproxen Product Two of PharmEvo

Table Naproxen Sales, Revenue, Price and Gross Margin of PharmEvo 2013-2017

Table Representative Naproxen Product One of APOTEX

Table Representative Naproxen Product Two of APOTEX

Table Naproxen Sales, Revenue, Price and Gross Margin of APOTEX 2013-2017

Table Representative Naproxen Product One of Schazoo

Table Representative Naproxen Product Two of Schazoo

Table Naproxen Sales, Revenue, Price and Gross Margin of Schazoo 2013-2017

Table Representative Naproxen Product One of Aspen Pharmacare

Table Representative Naproxen Product Two of Aspen Pharmacare

Table Naproxen Sales, Revenue, Price and Gross Margin of Aspen Pharmacare 2013-2017

List Of Figures, Charts and Diagrams
in Multiple Myeloma Treatment-Global Market Status and Trend Report 2013-2023 [Report Updated: 23-10-2017]

List of Figures


Figure Representative Commercial Product Picture of Naproxen

Figure United States Consumption Volume Share of Naproxen by Types in 2017

Figure Representative Commercial Product Picture of Tablet

Figure Representative Commercial Product Picture of Capsule

Figure Representative Commercial Product Picture of Other

Figure Demand Volume Share of Naproxen by Downstream Industry in 2017

Figure Application 1 Examples of Naproxen

Figure Application 2 Examples of Naproxen

Figure Application 3 Examples of Naproxen

Figure Application 4 Examples of Naproxen

Figure Application 5 Examples of Naproxen

Figure United States Naproxen Revenue and Growth Rate 2013-2023

Figure United States Naproxen Market Size Comparison in 2013, 2017 and 2023

Figure New England Naproxen Revenue and Growth Rate 2013-2023

Figure The Middle Atlantic Naproxen Revenue and Growth Rate 2013-2023

Figure The Midwest Naproxen Revenue and Growth Rate 2013-2023

Figure The West Naproxen Revenue and Growth Rate 2013-2023

Figure The South Naproxen Revenue and Growth Rate 2013-2023

Figure Southwest Naproxen Revenue and Growth Rate 2013-2023

Figure Consumption Volume and Growth Rate of Naproxen in United States 2013-2017

Figure Revenue and Growth Rate of Naproxen in United States 2013-2017

Figure Consumption Volume Share of Naproxen in United States by Regions 2013-2017

Figure Consumption Volume Share of Naproxen in United States by Regions in 2013

Figure Consumption Volume Share of Naproxen in United States by Regions in 2017

Figure Consumption Volume Growth Rate Comparison of Naproxen in United States by Regions 2013-2017

Figure Revenue Share of Naproxen in United States by Regions 2013-2017

Figure Revenue Share of Naproxen in United States by Regions in 2013

Figure Revenue Share of Naproxen in United States by Regions in 2017

Figure Revenue Growth Rate Comparison of Naproxen in United States by Regions 2013-2017

Figure Consumption Volume and Growth Rate of Naproxen in New England 2013-2017

Figure Revenue and Growth Rate of Naproxen in New England 2013-2017

Figure Consumption Volume and Growth Rate of Naproxen in The Middle Atlantic 2013-2017

Figure Revenue and Growth Rate of Naproxen in The Middle Atlantic 2013-2017

Figure Consumption Volume and Growth Rate of Naproxen in The Midwest 2013-2017

Figure Revenue and Growth Rate of Naproxen in The Midwest 2013-2017

Figure Consumption Volume and Growth Rate of Naproxen in The West 2013-2017

Figure Revenue and Growth Rate of Naproxen in The West 2013-2017

Figure Consumption Volume and Growth Rate of Naproxen in The South 2013-2017

Figure Revenue and Growth Rate of Naproxen in The South 2013-2017

Figure Consumption Volume and Growth Rate of Naproxen in Southwest 2013-2017

Figure Revenue and Growth Rate of Naproxen in Southwest 2013-2017

Figure Consumption Volume and Growth Rate of Naproxen in United States 2018-2023

Figure Revenue and Growth Rate of Naproxen in United States 2018-2023

Figure Consumption Volume Share of Naproxen in United States by Regions in 2023

Figure Revenue Share of Naproxen in United States by Regions in 2023

Figure Consumption Volume Share of Naproxen in United States by Types 2013-2017

Figure Consumption Volume Share of Naproxen in United States by Types in 2013

Figure Consumption Volume Share of Naproxen in United States by Types in 2017

Figure Consumption Volume Growth Rate Comparison of Naproxen in United States by Types 2013-2017

Figure Revenue Share of Naproxen in United States by Types 2013-2017

Figure Revenue Share of Naproxen in United States by Types in 2013

Figure Revenue Share of Naproxen in United States by Types in 2017

Figure Revenue Growth Rate Comparison of Naproxen in United States by Types 2013-2017

Figure 2013 Consumption Volume Share of Naproxen by Types in New England

Figure 2017 Consumption Volume Share of Naproxen by Types in New England

Figure 2013 Consumption Volume Share of Naproxen by Types in The Middle Atlantic

Figure 2017 Consumption Volume Share of Naproxen by Types in The Middle Atlantic

Figure 2013 Consumption Volume Share of Naproxen by Types in The Midwest

Figure 2017 Consumption Volume Share of Naproxen by Types in The Midwest

Figure 2013 Consumption Volume Share of Naproxen by Types in The West

Figure 2017 Consumption Volume Share of Naproxen by Types in The West

Figure 2013 Consumption Volume Share of Naproxen by Types in The South

Figure 2017 Consumption Volume Share of Naproxen by Types in The South

Figure 2013 Consumption Volume Share of Naproxen by Types in Southwest

Figure 2017 Consumption Volume Share of Naproxen by Types in Southwest

Figure Consumption Volume Share Forecast of Naproxen in United States by Types in 2023

Figure Revenue Share Forecast of Naproxen in United States by Types in 2023

Figure Demand Volume Share of Naproxen in United States by Downstream Industry 2013-2017

Figure Demand Volume Share of Naproxen in United States by Downstream Industry in 2013

Figure Demand Volume Share of Naproxen in United States by Downstream Industry in 2017

Figure Demand Volume Growth Rate Comparison of Naproxen in United States by Downstream Industry 2013-2017

Figure 2013 Demand Volume Share of Naproxen by Downstream Industry in New England

Figure 2017 Demand Volume Share of Naproxen by Downstream Industry in New England

Figure 2013 Demand Volume Share of Naproxen by Downstream Industry in The Middle Atlantic

Figure 2017 Demand Volume Share of Naproxen by Downstream Industry in The Middle Atlantic

Figure 2013 Demand Volume Share of Naproxen by Downstream Industry in The Midwest

Figure 2017 Demand Volume Share of Naproxen by Downstream Industry in The Midwest

Figure 2013 Demand Volume Share of Naproxen by Downstream Industry in The West

Figure 2017 Demand Volume Share of Naproxen by Downstream Industry in The West

Figure 2013 Demand Volume Share of Naproxen by Downstream Industry in The South

Figure 2017 Demand Volume Share of Naproxen by Downstream Industry in The South

Figure 2013 Demand Volume Share of Naproxen by Downstream Industry in Southwest

Figure 2017 Demand Volume Share of Naproxen by Downstream Industry in Southwest

Figure Demand Volume Share Forecast of Naproxen in United States by Downstream Industry in 2023

Figure Sales Volume Share of Naproxen in United States by Major Players in 2013

Figure Sales Volume Share of Naproxen in United States by Major Players in 2017

Figure Revenue Share of Naproxen in United States by Major Players in 2013

Figure Revenue Share of Naproxen in United States by Major Players in 2017

Figure Naproxen Revenue and United States Share of Roche 2013-2017

Figure Naproxen Revenue and United States Share of Divis Laboratories 2013-2017

Figure Naproxen Revenue and United States Share of Taj Pharmaceuticals Limited 2013-2017

Figure Naproxen Revenue and United States Share of GLORIA 2013-2017

Figure Naproxen Revenue and United States Share of HUANLON 2013-2017

Figure Naproxen Revenue and United States Share of PKU HIGH-TECH HUATAI 2013-2017

Figure Naproxen Revenue and United States Share of SINE 2013-2017

Figure Naproxen Revenue and United States Share of Bayer 2013-2017

Figure Naproxen Revenue and United States Share of YAOPHARMA 2013-2017

Figure Naproxen Revenue and United States Share of PharmEvo 2013-2017

Figure Naproxen Revenue and United States Share of APOTEX 2013-2017

Figure Naproxen Revenue and United States Share of Schazoo 2013-2017

Additional Details

Publisher

MIReports

Publisher Information

Headquartered in Haidian District, Beijing, MIReports is a global information consulting company, focusing on market data collection and professional analysis.

Reference

135915 |

Number of Pages

136

Report Format

PDF

MIReports Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Physician Views: Sanofi's Lemtrada finally approved in the US – how will neurologists use the multiple sclerosis therapy?
Scope Two years after it was first submitted for approval with the FDA, Sanofi's multiple sclerosis ...
25 Nov 2014 by FirstWord Pharma USD $695 More Info
KOL Insight: Multiple Sclerosis
IntroductionRecent launches of oral therapies have brought clinical advantages and clear patient ben...
06 Oct 2014 by FirstWord Pharma USD $7,900 More Info
Physician Views: How do neurologists value multiple sclerosis medical affairs teams – what could they be doing better?
Scope Medical affairs teams are playing an increasingly critical role for pharmaceutical manufacture...
18 Jun 2014 by FirstWord Pharma USD $695 More Info
Physician Views: What drives physician brand loyalty in the ultra-competitive multiple sclerosis market?
Scope The multiple sclerosis market is arguably one of the most competitive in pharma, shaped in par...
05 May 2014 by FirstWord Pharma USD $695 More Info
Physician Views: Life-cycle management strategies in multiple sclerosis – can new versions of Copaxone, Avonex drive market share retention?
Scope With Copaxone and Avonex generating global sales of .3 billion and billion for Teva and B...
26 Mar 2014 by FirstWord Pharma USD $695 More Info
Multiple Sclerosis: KOL Insight
IntroductionThe multiple sclerosis treatment landscape has undergone dramatic changes over the past ...
01 Dec 2013 by FirstWord Pharma USD $7,900 More Info
Consensus Outlook: Multiple Sclerosis
IntroductionOver the next five years, the global multiple sclerosis (MS) market is set to grow from ...
01 Dec 2013 by FirstWord Pharma USD $4,995 More Info
Physician Views – Which multiple sclerosis players do the best marketing job? – FirstWord polls neurologists in the US and 5EU
ScopeThe multiple sclerosis market has undergone notable change over the past 2 years, primarily due...
01 Sep 2013 by FirstWord Pharma USD $695 More Info
Physician Views: Sanofi secures EU approval for its multiple sclerosis treatment Lemtrada – how will neurologists use it?
ScopeWith Sanofi securing European approval for its multiple sclerosis therapy Lemtrada last week, n...
01 Sep 2013 by FirstWord Pharma USD $695 More Info
Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules
IntroductionThe multiple sclerosis treatment landscape has undergone dramatic changes over the past ...
12 Mar 2013 by FirstWord Pharma USD $7,495 More Info

This report is published by MIReports

Headquartered in Haidian District, Beijing, MIReports is a global information consulting company, focusing on market data collection and professional analysis.

Download Free Report Summary PDF

Multiple Myeloma Treatment-Global Market Status and Trend Report 2013-2023 [Report Updated: 23-10-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...